|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 26, 393-395, Copyright © 1985 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
AL Southren, GG Gordon, D l'Hommedieu, S Ravikumar, MW Dunn and BI Weinstein
5 beta-dihydrocortisol potentiates the action of topically applied dexamethasone in raising the intraocular pressure (IOP) in young rabbits. Dexamethasone (0.06%) plus 5 beta-dihydrocortisol (0.1 and 1.0%) elevated the IOP 7-10 mmHg within 18 days of treatment. By contrast, 0.06% dexamethasone alone raised the IOP 3 to 4 mmHg in a similar period of time. Since 5 beta-dihydrocortisol accumulates abnormally in cultured cells derived from the outflow region of the eye from patients with primary open angle glaucoma (POAG), a similar potentiation in man may account for the sensitivity of these patients to the IOP raising effect of glucocorticoids. Further, this metabolite may potentiate endogenous glucocorticoids resulting in the ocular hypertension characteristic of POAG.
This article has been cited by other articles:
![]() |
W. R. Lo, L. L. Rowlette, M. Caballero, P. Yang, M. R. Hernandez, and T. Borras Tissue Differential Microarray Analysis of Dexamethasone Induction Reveals Potential Mechanisms of Steroid Glaucoma Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 473 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melena, J. Santafé, and J. Segarra The Effect of Topical Diltiazem on the Intraocular Pressure in Betamethasone-Induced Ocular Hypertensive Rabbits J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 278 - 282. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |